GLP1 Gold Rush: Weight Loss Drugs' Cancer Link, Ozempic vs Mounjaro, Invest in Your Health & Wealth!
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
GLP1 Gold Rush: Weight Loss Drugs' Cancer Link, Ozempic vs Mounjaro, Invest in Your Health & Wealth!
-
Narrated by:
-
By:
About this listen
Episode 27
00:00 Market Overview and V-Shaped Recovery
06:44 Investing Strategies and TFSA Benefits
12:43 Health and Wealth: The Importance of Advocacy
18:42 Pharmaceutical Stocks and Market Dynamics
24:37 The Impact of GLP-1 Drugs on Cancer Risk
30:43 Understanding Muscle Loss with GLP-1s
35:40 The Importance of Exercise and Personal KPIs
Host descriptions:
Catherine Murray, a business newscaster and former Wall Street professional at Goldman, William Blair and Deutsche bank.
Dr. Melissa Hershberg, a medical practitioner with a specialized interest in preventive health, weight loss and aesthetic medicine.
Disclaimer: for entertainment purposes only, please do your own research, your own homework and consult with a financial advisor for investment discussions. In addition to consulting with your Family Doctor, Physician, GP or other health care providers before making any health and beauty decisions